Home NDC 63304-845 Metoclopramide
Product NDC 63304-845
11-digit product format 633040845
Labeler code 63304
Product ID 63304-845_38615cef-95ad-4574-b433-422037e5658d
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Metoclopramide
Dosage form TABLET
Route ORAL
Labeler Ranbaxy Pharmaceuticals Inc.
Application ANDA078807
Marketing category ANDA
Marketing start 2009-03-13
Marketing end 0000-00-00
Substance METOCLOPRAMIDE HYDROCHLORIDE
Active strength 5 mg/1
Pharmacologic classes Dopamine D2 Antagonists [MoA],Dopamine-2 Receptor Antagonist [EPC]
NDC exclude flag E
Listing certified through 2017-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 2 · 110 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 63304-845-01 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 63304-845-10 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 63304-845-05 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 63304-845-30 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 63304-845-01 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 63304-845-10 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 63304-845-05 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 63304-845-30 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 63304-845-01 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 63304-845-10 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 63304-845-05 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 63304-845-30 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 63304-845-01 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 63304-845-10 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 63304-845-05 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 63304-845-30 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 63304-845-01 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 63304-845-10 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 63304-845-05 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 63304-845-30 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 63304-845-01 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 63304-845-10 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 63304-845-05 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 63304-845-30 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product D Discontinued by firm 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 63304-845-01 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 63304-845-10 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 63304-845-05 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 63304-845-30 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 63304-845-01 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 63304-845-10 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 63304-845-05 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 63304-845-30 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 63304-845-01 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 63304-845-10 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 63304-845-05 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 63304-845-30 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 63304-845-10 I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 63304-845-05 I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 63304-845-01 I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 63304-845-30 I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 63304-845-10 I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 63304-845-05 I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 63304-845-01 I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 63304-845-30 I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 63304-845-10 I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 63304-845-05 I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 63304-845-01 I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 63304-845-30 I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A078807-001 METOCLOPRAMIDE HYDROCHLORIDE METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE TABLET / ORAL AB 2008-06-12 A078807-002 METOCLOPRAMIDE HYDROCHLORIDE METOCLOPRAMIDE HYDROCHLORIDE EQ 10MG BASE TABLET / ORAL AB 2008-06-12
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 82 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A078807-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE TABLET / ORAL AB 2008-06-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A078807-002 METOCLOPRAMIDE HYDROCHLORIDE EQ 10MG BASE TABLET / ORAL AB 2008-06-12 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A078807-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE TABLET / ORAL AB 2008-06-12 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A078807-002 METOCLOPRAMIDE HYDROCHLORIDE EQ 10MG BASE TABLET / ORAL AB 2008-06-12 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A078807-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE TABLET / ORAL AB 2008-06-12 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A078807-002 METOCLOPRAMIDE HYDROCHLORIDE EQ 10MG BASE TABLET / ORAL AB 2008-06-12 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A078807-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE TABLET / ORAL AB 2008-06-12 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A078807-002 METOCLOPRAMIDE HYDROCHLORIDE EQ 10MG BASE TABLET / ORAL AB 2008-06-12 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A078807-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE TABLET / ORAL AB 2008-06-12 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A078807-002 METOCLOPRAMIDE HYDROCHLORIDE EQ 10MG BASE TABLET / ORAL AB 2008-06-12 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A078807-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE TABLET / ORAL AB 2008-06-12 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A078807-002 METOCLOPRAMIDE HYDROCHLORIDE EQ 10MG BASE TABLET / ORAL AB 2008-06-12 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A078807-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE TABLET / ORAL AB 2008-06-12 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A078807-002 METOCLOPRAMIDE HYDROCHLORIDE EQ 10MG BASE TABLET / ORAL AB 2008-06-12 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A078807-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE TABLET / ORAL AB 2008-06-12 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A078807-002 METOCLOPRAMIDE HYDROCHLORIDE EQ 10MG BASE TABLET / ORAL AB 2008-06-12 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A078807-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE TABLET / ORAL AB 2008-06-12 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A078807-002 METOCLOPRAMIDE HYDROCHLORIDE EQ 10MG BASE TABLET / ORAL AB 2008-06-12 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A078807-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE TABLET / ORAL AB 2008-06-12 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A078807-002 METOCLOPRAMIDE HYDROCHLORIDE EQ 10MG BASE TABLET / ORAL AB 2008-06-12 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A078807-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE TABLET / ORAL AB 2008-06-12 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A078807-002 METOCLOPRAMIDE HYDROCHLORIDE EQ 10MG BASE TABLET / ORAL AB 2008-06-12 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A078807-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE TABLET / ORAL AB 2008-06-12 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A078807-002 METOCLOPRAMIDE HYDROCHLORIDE EQ 10MG BASE TABLET / ORAL AB 2008-06-12 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A078807-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE TABLET / ORAL AB 2008-06-12 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A078807-002 METOCLOPRAMIDE HYDROCHLORIDE EQ 10MG BASE TABLET / ORAL AB 2008-06-12 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A078807-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE TABLET / ORAL AB 2008-06-12 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A078807-002 METOCLOPRAMIDE HYDROCHLORIDE EQ 10MG BASE TABLET / ORAL AB 2008-06-12 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A078807-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE TABLET / ORAL AB 2008-06-12 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A078807-002 METOCLOPRAMIDE HYDROCHLORIDE EQ 10MG BASE TABLET / ORAL AB 2008-06-12 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A078807-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE TABLET / ORAL AB 2008-06-12 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 A078807-002 METOCLOPRAMIDE HYDROCHLORIDE EQ 10MG BASE TABLET / ORAL AB 2008-06-12 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A078807-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE TABLET / ORAL AB 2008-06-12 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 A078807-002 METOCLOPRAMIDE HYDROCHLORIDE EQ 10MG BASE TABLET / ORAL AB 2008-06-12 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A078807-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE TABLET / ORAL AB 2008-06-12 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 A078807-002 METOCLOPRAMIDE HYDROCHLORIDE EQ 10MG BASE TABLET / ORAL AB 2008-06-12 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A078807-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE TABLET / ORAL AB 2008-06-12 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 A078807-002 METOCLOPRAMIDE HYDROCHLORIDE EQ 10MG BASE TABLET / ORAL AB 2008-06-12 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A078807-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE TABLET / ORAL AB 2008-06-12 782e0a99824c…2021-12-28 21:50 UTC 2021-12 A078807-002 METOCLOPRAMIDE HYDROCHLORIDE EQ 10MG BASE TABLET / ORAL AB 2008-06-12 782e0a99824c…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 82 observed states.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# NDC, Effective, Related label table NDC Effective Related label 63304-845-01 2024-12-24 Metoclopramide Tablets, USP 63304-845-05 2024-12-24 Metoclopramide Tablets, USP 63304-845-10 2024-12-24 Metoclopramide Tablets, USP 63304-845-30 2024-12-24 Metoclopramide Tablets, USP 63304-845-01 2019-11-13 Metoclopramide Tablets, USP 63304-845-05 2019-11-13 Metoclopramide Tablets, USP 63304-845-10 2019-11-13 Metoclopramide Tablets, USP 63304-845-30 2019-11-13 Metoclopramide Tablets, USP
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded METOCLOPRAMIDE HYDROCHLORIDE ACTIVE INGREDIENT W1792A2RVD METOCLOPRAMIDE TABLET [RANBAXY PHARMACEUTICALS INC.] 5 METOCLOPRAMIDE ACTIVE MOIETY L4YEB44I46 METOCLOPRAMIDE TABLET [RANBAXY PHARMACEUTICALS INC.] 5 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U METOCLOPRAMIDE TABLET [RANBAXY PHARMACEUTICALS INC.] 5 COLLOIDAL SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 METOCLOPRAMIDE TABLET [RANBAXY PHARMACEUTICALS INC.] 5 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ METOCLOPRAMIDE TABLET [RANBAXY PHARMACEUTICALS INC.] 5 STEARIC ACID INACTIVE INGREDIENT 4ELV7Z65AP METOCLOPRAMIDE TABLET [RANBAXY PHARMACEUTICALS INC.] 5 METOCLOPRAMIDE HYDROCHLORIDE ACTIVE INGREDIENT W1792A2RVD METOCLOPRAMIDE TABLET [PHYSICIANS TOTAL CARE, INC.] 3 METOCLOPRAMIDE ACTIVE MOIETY L4YEB44I46 METOCLOPRAMIDE TABLET [PHYSICIANS TOTAL CARE, INC.] 3 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U METOCLOPRAMIDE TABLET [PHYSICIANS TOTAL CARE, INC.] 3 COLLOIDAL SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 METOCLOPRAMIDE TABLET [PHYSICIANS TOTAL CARE, INC.] 3 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ METOCLOPRAMIDE TABLET [PHYSICIANS TOTAL CARE, INC.] 3 STEARIC ACID INACTIVE INGREDIENT 4ELV7Z65AP METOCLOPRAMIDE TABLET [PHYSICIANS TOTAL CARE, INC.] 3
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
DailyMed RxNorm Mappings#